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Thousands of large intergenic noncoding RNAs (lincRNAs) have
been identified in the mammalian genome, many of which have
important roles in regulating a variety of biological processes.
Here, we used a custom microarray to identify lincRNAs associated
with activation of the innate immune response. A panel of 159
lincRNAs was found to be differentially expressed following
innate activation of THP1 macrophages. Among them, linc1992
was shown to be expressed in many human tissues and was
required for induction of TNFα expression. Linc1992 bound specif-
ically to heterogenous nuclear ribonucleoprotein L (hnRNPL) and
formed a functional linc1992–hnRNPL complex that regulated tran-
scription of the TNFα gene by binding to its promoter. Transcrip-
tome analysis revealed that linc1992 was required for expression
of many immune-response genes, including other cytokines and
transcriptional and posttranscriptional regulators of TNFα expres-
sion, and that knockdown of linc1992 caused dysregulation of
these genes during innate activation of THP1 macrophages. There-
fore, we named linc1992 THRIL (TNFα and hnRNPL related immu-
noregulatory LincRNA). Finally, THRIL expression was correlated
with the severity of symptoms in patients with Kawasaki disease,
an acute inflammatory disease of childhood. Collectively, our data
provide evidence that lincRNAs and their binding proteins can reg-
ulate TNFα expression and may play important roles in the innate
immune response and inflammatory diseases in humans.
innate immunity | inflammation | Toll-like receptors
Vertebrates are constantly exposed to microbial pathogensthat can disrupt normal cellular processes and lead to dis-
eases (1). The innate immune response has evolved as a rapidly
mobilized first line of defense against such threats and is initiated
by engagement of several classes of cell surface and intracellular
pattern-recognition receptors (PRRs) that include the trans-
membrane Toll-like receptors (TLRs) (1, 2). TLRs recognize
a variety of microbial molecules, including lipopeptides, lipo-
polysaccharides, and DNA, that trigger intracellular signaling
cascades that activate transcription factors such as NFκB and
IFN regulatory factors (IRFs). NFκB and IRFs regulate the
expression of hundreds of genes involved in the immune re-
sponse, including the proinflammatory cytokines TNFα, interleukin
(IL)-1, and IL-6 (1, 2). The innate immune response must thus be
tightly controlled to limit potential damage from excess inflam-
matory mediators and to allow tissue repair following infection.
In recent years, it has become clear that noncoding RNAs
(ncRNAs) such as microRNAs play important regulatory roles in
TLR signaling in response to microbial stimuli, acting at both the
transcriptional and posttranscriptional levels (3, 4). However,
microRNAs are only a small fraction of the noncoding regions of
the mammalian genome, and additional ncRNAs, including large
intergenic noncoding RNAs (lincRNAs), are expressed abun-
dantly (5). LincRNAs are encoded similarly to coding genes but
do not contain protein-coding sequences in the transcripts.
LincRNAs are evolutionarily conserved, and emerging evidence
suggests that they play key roles in a diverse array of cellular
processes such as X-chromosome inactivation (6), p53 pathway
regulation (7), cell-cycle control (8), epigenetic regulation (9–
11), self-renewal of embryonic stem cells (12), and embryonic
development (13). Moreover, recent studies have indicated that
mutation and/or dysregulated expression of lincRNAs could play
a role in multiple human diseases, including cancer (9, 14),
suggesting that they could be therapeutic targets. LincRNAs are
thought to function primarily through specific interactions with
cellular proteins, and a panel of these proteins have been iden-
tified (6, 10, 11, 15, 16). However, it is clear that other cellular
lincRNA-binding factors and cell type-specific functions remain
to be identified.
In this study, we identified a lincRNA that regulates the hu-
man macrophage response to an innate stimulus, suggesting that
lincRNAs may play an unappreciated role in regulating cell-
defense mechanisms and host–pathogen interactions. We designed
a custom human lincRNA microarray to detect genome-wide
changes in the expression of lincRNAs in a classical model of in-
nate immune cell activation. The human THP1 monocyte cell line
was differentiated to macrophage-like cells and stimulated with
a synthetic lipopeptide ligand of TLR2. We identified a panel of
159 lincRNAs that were highly modulated in stimulated THP1
macrophages, one of which, linc1992, was essential for induction of
TNFα, a critical cytokine released early in the innate immune re-
sponse. Linc1992 functions through interactions with heteroge-
neous nuclear ribonucleoprotein L (hnRNPL), which is highly
expressed in THP1-derived macrophages but not known to be
involved in regulating TNFα expression. HnRNPL is an RNA-
binding protein found inside and outside the nucleolus. HnRNPL
is one of the members of a family of proteins that associate with
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hnRNAs (such as pre-mRNAs and mRNAs) and play major
roles in the formation, packaging, and processing of mRNA (17).
Recent studies indicate that hnRNPL is involved in the mam-
malian stress response and plays dual roles in the nucleus and
cytoplasm (18, 19). In the nucleus, hnRNPL binds L1 retro-
transposon RNAs and helps to silence endogenous retrotransposon
expression (19) whereas, in the cytoplasm, hnRNPL is involved
in a stress-responsive switch that controls VEGFA expression (18).
However, the extent to which hnRNPL can bind other RNAs and
regulate additional mammalian functions remains unclear. Given
its close relationship with TNFα and hnRNPL, we named linc1992
THRIL (TNFα and hnRNPL related immunoregulatory LincRNA).
Importantly, decreased THRIL expression was correlated with the
acute phase of Kawasaki disease, an inflammatory disease of chil-
dren, substantiating the importance of lincRNAs as regulators of
physiological and pathological inflammatory immune responses.
Results
Many lincRNAs Are Highly Regulated During Innate Activation of
Macrophages. We hypothesized that, if lincRNAs are involved
in regulating innate immunity, their expression would likely be
tightly controlled following cell stimulation with ligands of the
innate immune system. To test this hypothesis, we designed a
custom lincRNA microarray. cDNA sequences of all known
human lincRNAs were extracted from two sources and used for
probe design: 1,703 defined lincRNA transcripts were from the
Ensembl database (release 61) and 2,915 transcripts were from
the Havana database, as previously reported (20). Overall, 5–8
probes were designed per transcript, and ∼26,000 commercially
available mRNA probes were also included in the array for
quality control. We chose the THP1 monocyte cell line as the
model system because it has been used extensively to study the
response of monocytes/macrophages to innate ligands, as well as
the role of small ncRNAs in regulating the immune response (3,
4). THP1 cells differentiate into macrophage-like cells upon
treatment with phorbol-12-myristate-13-acetate (PMA), allowing
macrophages to be produced in culture in large quantities. To
prepare cell samples for microarray analysis, THP1-derived
macrophages were stimulated with Pam3CSK4 (Pam), a syn-
thetic lipopeptide that induces proinflammatory gene expression
(Fig. 1A). To identify changes in lincRNA expression early in the
response, we harvested total RNA 8 h after treatment with Pam.
These conditions have been used previously for microRNA
studies in THP1 cells (4). We first validated the performance of
our probes by comparing two independent samples of unstimu-
lated or Pam-stimulated THP1 macrophages (Fig. S1A). Overall,
the lincRNA probes performed as well as the established mRNA
probes and exhibited good linear correlation between the two
samples (Fig. S1A). From the microarray data, a lincRNA was
classified as a hit if expression was suppressed or induced in both
samples with at least 1.9-fold change and a P value < 0.05. We
identified 159 unique lincRNAs (240 probes) that were highly
induced or suppressed in THP1 macrophages following Pam
stimulation, of which 80% (127 lincRNAs, 191 probes) were
suppressed and 20% (32 lincRNAs, 49 probes) were induced (Fig.
1B). These observations suggested that lincRNAs were largely
suppressed during TLR2 activation of THP1 macrophages.
To validate the microarray data, 20 candidate lincRNAs were
selected for validation by RT-qPCR based on the change in ex-
pression (1.9-fold, P < 0.05), the number of detected probes, and
the context of genes within 1 Mb of the lincRNA locus. Of the
20 candidate lincRNAs analyzed, 15 were confirmed to be ex-
pressed in THP1 macrophages (Fig. S1B). RT-qPCR analysis
detected the same pattern of expression upon Pam treatment as
that determined by microarray analysis (Fig. 1C), but the change
was statistically significant for only 9 of the 15 lincRNAs. There
are at least two explanations for the discrepancy between the
number of differentially expressed lincRNAs identified by
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Fig. 1. Identification of lincRNAs associated with innate
immunity. (A) Experimental design. THP1 macrophages
were treated with 100 ng/mL innate activator Pam3CSK4
(Pam) for 8 h, and total RNA was then harvested for
microarray analysis. (B) Heat map of 159 lincRNAs (240
probes) significantly changed upon Pam stimulation of
THP1 macrophages. (C) RT-qPCR analysis of lincRNAs fol-
lowing treatment of THP1 macrophages with Pam for 8 h.
Results are mean ± SD of two independent experiments
with duplicate wells. *P < 0.05. (D and E) TNFα (D) and IL-
6 (E) release from THP1 macrophages expressing control
shRNA (NonT) or shRNAs targeting the indicated lincR-
NAs. Cells were treated with Pam for 24 h, and culture
supernatants were collected for ELISA. Results are
expressed relative to secretion from NonT shRNA cells
and are mean ± SD of five (D) or four (E) independent
experiments with duplicate wells. **P < 0.01, ***P <
0.001. (F) RT-qPCR analysis of linc1992 expression in hu-
man tissues. Results are mean ± SD of duplicate wells. (G)
Expression of linc1992 in THP1 macrophages by Northern
blotting. (H) The 3′ RACE of linc1992. (I) The 5′ RACE of
linc1992.








microarray and RT-qPCR. First, the lincRNA sequences were
assembled from available cDNA libraries that have not been ac-
curately mapped; thus, the qPCR primers may not detect the same
transcripts as the array probes. Alternatively, some of the micro-
array probes may have given false-positive signals. Nevertheless,
using a combination of microarray and RT-qPCR, we successfully
identified a number of lincRNAs that were highly regulated during
activation of THP1 macrophages by Pam.
Several lincRNAs Regulate Induction of Proinflammatory Cytokines.
We next determined whether the nine differentially expressed
lincRNAs could regulate the THP1 macrophage response to
Pam (Fig. 1C). THP1 cells were infected with two shRNAs for
each lincRNA and treated with PMA to induce cell differenti-
ation. Eight of the nine lincRNAs (the exception being linc8986)
were confirmed to be efficiently knocked down by at least one of
the shRNAs (Fig. S2A). To determine the effect of lincRNA
knockdown on cytokine secretion, shRNA-infected THP1 mac-
rophages were treated with Pam for 24 h, and the concentra-
tions of proinflammatory cytokines TNFα and IL-6 in the
supernatants were measured by ELISA. We found that knock-
down of several of the lincRNAs modulated TNFα (Fig. 1D) and
IL-6 (Fig. 1E) secretion. These results were confirmed with a
second set of shRNAs to exclude the possibility of off-target
effects (Fig. S2 B and C). Among the tested lincRNAs, knock-
down of linc1992 strongly suppressed TNFα induction, and two
of the three shLinc1992s tested also strongly suppressed IL-6
induction (Figs. 1 D and E and Fig. S2 B and C). Analysis of
lincRNA expression in 20 different human tissues revealed that
linc1992 was widely distributed whereas most of the remaining
eight lincRNAs examined showed more tissue-restricted expres-
sion patterns (Fig. 1F and Fig. S2D).
The size of linc1992 was examined by Northern blotting and
shown to be ∼2–2.5 kb in length (Fig. 1G). We used 5′ and 3′
RACE to map the exact sequence of linc1992, which is located in
the reverse strand of the in cis gene Bri3bp with ∼450 bp over-
lapping with the BRI3 binding protein (Bri3bp) mRNA 3′ UTR
(Fig. 1 H and I). The RACE results identified two ∼2-kb iso-
forms of linc1992, which differed only slightly in the first 40–50
nucleotides of the 5′ end (SI Materials and Methods). Linc1992
was confirmed by in vitro translation analysis to be a noncoding
RNA (Fig. S1 C–E) and was present in THP1 macrophages at
approximately eight copies per cell (Fig. S1F). Collectively, these
results identified several lincRNAs that regulate proinflam-
matory cytokine induction during activation of THP1 macro-
phages. One of them, linc1992, is an ∼2-kb RNA with a broad
expression profile and regulates secretion of TNFα, a cytokine
that plays a critical role in the innate immune response.
Linc1992 Regulates TNFα Expression Through a Negative Feedback
Mechanism. Because knockdown of linc1992 strongly reduced
TNFα secretion following Pam stimulation of THP1 macro-
phages (Fig. 1D), we next asked whether linc1992 affects TNFα
mRNA or protein expression. We transduced THP1 macrophages
with four different shlinc1992s, each of which efficiently knocked
down linc1992 expression (Fig. 2A), and analyzed TNFα induction
in unstimulated or Pam-stimulated cells. Pam stimulation greatly
increased TNFα mRNA production (Fig. 2B) and protein secre-
tion (Fig. 2C) in cells transduced with nontargeting shRNA
(shNonT) whereas production of both TNFα mRNA and protein
were significantly lower in shLinc1992-expressing cells (Fig. 2 B
and C). TNFα and linc1992 expression following Pam treatment
was also examined in the human lung adenocarcinoma epithelial
cell line, A549, and the human monocyte-derived macrophages,
MDMs, with similar results (Fig. S3 A–C). Overexpression of
linc1992 rescued both linc1992 and TNFα expression in linc1992-
knockdown cells (Fig. S3 D and E), which further supports that
the effect of linc1992 shRNAs is specific. Thus, linc1992 appears
to regulate TNFα transcriptionally, although we cannot rule out
the possibility of additional posttranscriptional regulation. To
determine whether linc1992 knockdown delayed TNFα ex-
pression, rather than decreased the magnitude of the response,
we analyzed the time course of Pam-stimulated TNFα expres-
sion in THP1 macrophages expressing shNonT or shLinc1992. In
control cells, TNFα mRNA was detectable within 1 h of Pam
treatment and peaked at 2 h poststimulation (Fig. 2D) whereas
protein secretion reached maximal levels at 8 h and remained at
approximately the same level through 24 h, the last time point
examined (Fig. 2E). Linc1992 knockdown cells showed signifi-
cantly reduced levels of both TNFα mRNA and protein, as
expected, but the kinetics of induction was unaffected (Fig. 2 D
and E). Thus, knockdown of linc1992 affected the magnitude but
not the time course of TNFα induction by Pam. We further
analyzed the relative expression of TNFα and linc1992 after
Pam stimulation and discovered that linc1992 expression was
down-regulated once TNFα production was detectable (Fig. 2F),
suggesting that linc1992 may be part of a protective feedback
loop to control TNFα levels, a mechanism that has also been
proposed for microRNA function in innate immunity (4). To test
this hypothesis, unstimulated THP1 macrophages were treated
with purified recombinant human TNFα to avoid the possibility
of contamination with other cytokines, and the time course of
TNFα mRNA and linc1992 expression was analyzed over the
following 24 h (Fig. 2 G and H). We found that TNFα mRNA
expression was elevated as early as 1 h after addition of exoge-
nous TNFα and that this observation was mirrored by a decrease
in Linc1992 expression, confirming the negative feedback regu-
lation of linc1992 by TNFα. We also asked whether Pam-induced
down-regulation of linc1992 was dependent on the expression of
MyD88, a critical adapter protein for innate immune signaling (2,
21, 22). As expected, efficient shRNA-mediated knockdown of
MyD88 (Fig. S4A) was accompanied by a substantial reduction
in Pam-induced TNFα induction (Fig. S4B); however, linc1992
Fig. 2. Linc1992 regulates TNFα expression through a negative feedback
mechanism. (A) Knockdown of linc1992 in THP1 macrophages with three dis-
tinct shRNAs. Results are mean ± SD of two independent experiments with
duplicate wells. *P < 0.05. (B and C) TNFα mRNA expression in THP1 macro-
phages. TNFαmRNA (B) was quantified by RT-qPCR analysis, and secreted TNFα
(C) was quantified by ELISA. Results are mean ± SD of two (B) and three (C)
independent experiments with duplicate wells. *P < 0.05, **P < 0.01. (D and E)
Time course of TNFα mRNA (D) induction measured by RT-qPCR and secreted
TNFα (E) measured by ELISA in Pam-stimulated THP1 cells expressing control or
linc1992-specific shRNAs. Results are mean ± SD of duplicate wells. (F) Kinetics
of linc1992 and TNFα mRNA expression in Pam-stimulated THP1 macrophages.
Results are mean ± SD of duplicate wells. (G and H) Kinetics of TNFαmRNA (G)
and linc1992 (H) expression in TNFα-treated THP1 macrophages. Signals
were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
mRNA levels. Results are mean ± SD of duplicate wells.
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expression was unaffected (Fig. S4C). Notably, MyD88 mRNA
was reduced by Pam stimulation (Fig. S4A), suggesting that
MyD88 expression may also be subject to feedback regulation.
Together, these data suggest that regulation of linc1992 upon
innate activation occurs through MyD88-independent pathways.
Because linc1992 is located close to the coding gene Bri3bp
and lincRNAs have been reported to have cis-regulatory effects
on nearby genes (20), we investigated whether knockdown of
linc1992 affected the expression of its in cis genes. Indeed, linc1992
knockdown resulted in ∼50% reduction of Bri3bp mRNA (Fig.
S4D) but did not affect expression of other nearby genes such as
Aacs, Scarb1, Ubc, and Dhx37 (data not shown). To determine
whether the reduction in TNFα expression in linc1992 knockdown
cells was due to decreased expression of Bri3bp, we used two
shRNAs to efficiently knockdown Bri3bp expression (Fig. S4E).
Significantly, TNFα mRNA levels were reduced by 40–50% in
Pam-stimulated shBri3bp-expressing cells compared with cells
expressing shNonT (Fig. S4E). We reasoned that, if TNFα regu-
lation by linc1992 was mediated solely through Bri3bp, Bri3bp
overexpression should rescue the linc1992 knockdown phenotype.
Although lentiviral-mediated overexpression of Bri3bp (Fig. S4F)
increased Pam-induced TNFα induction in control THP1 cells,
it could not rescue the reduction in TNFα caused by linc1992
knockdown (Fig. S4G). It is also worth noting that Bri3bp knock-
down did not significantly affect hnRNPL expression (Fig. S4H).
These data therefore suggest that Bri3bp is not the dominant me-
diator of linc1992 regulation of TNFα expression although de-
creased Bri3bp expression may contribute to the phenotype.
Linc1992 Interacts with hnRNPL to Regulate TNFα Induction. LincRNAs
usually function by physically interacting with other cellular factors
(9–11, 15, 16). To determine how linc1992 regulates TNFα ex-
pression, we sought to identify intracellular linc1992-binding fac-
tors using an unbiased approach. Full-length linc1992 was in vitro
transcribed with biotinylated nucleotides (Fig. S5A), and biotin
incorporation was confirmed by dot blotting (Fig. S5B). Bio-
tinylated linc1992 (or partial lacZ mRNA without protein-coding
potential as a negative control) was then incubated with total
protein extracts from THP1 macrophages and pulled down with
streptavidin. The associated proteins were analyzed by SDS/PAGE
and silver staining (Fig. 3A). Two distinct bands specifically present
in the linc1992 pull-down samples (Fig. 3B) were excised and an-
alyzed by mass spectrometry, which identified four potential bind-
ing proteins: hnRNPL, DDX5, NONO, and vimentin. To confirm
that the proteins specifically interact with linc1992, we repeated the
pull-down assay with biotinylated linc1992 and probed for the four
proteins by Western blot analysis. Only hnRNPL was confirmed
to be bound specifically to linc1992 (Fig. 3C). To identify the
hnRNPL-interacting region of linc1992, three fragments of linc1992
(1–699, 700–1405, and 1406–2012) were biotinylated and used in
the pull-down assay with THP1 lysates. These experiments showed
that the 5′ fragment and, to a lesser extent, the 3′ fragment of
linc1992 mediated the interaction with hnRNPL (Fig. 3D). To
substantiate these observations, anti-hnRNPL antibody was used to
immunoprecipitate endogenous hnRNPL from nuclear extracts of
THP1 macrophages, and RNAs bound to hnRNPL were extracted
and analyzed. We detected ∼sixfold enrichment of linc1992, but
not control GAPDH RNA, in the anti-hnRNPL immunoprecipi-
tates compared with the IgG control (Fig. 3E). These results
confirmed that linc1992 and hnRNPL can form an RNP complex
in vivo. We next asked whether hnRNPL was necessary for Pam-
induced TNFα expression in these cells. HnRNPL expression was
depleted using five different shRNAs, all of which were confirmed
to efficiently knock down hnRNPL mRNA levels (Fig. S5C). No-
tably, knockdown of hnRNPL resulted in a dramatic decrease in
Pam-stimulated TNFα induction (Fig. 3F) but did not affect ex-
pression of Bri3bp (Fig. S5C). Linc1992 expression was moderately
decreased in shhnRNPL-expressing cells (Fig. S5D), possibly due
to destabilization.
We noted that hnRNPL knockdown not only affected Pam-
stimulated TNFα expression in THP1 macrophages, but also sig-
nificantly decreased basal TNFα mRNA expression (Fig. 3G), a
phenomenon also observed in linc1992 knockdown cells (Fig. 3H).
Overexpression of linc1992 (Fig. S5E) significantly up-regulated
basal TNFαmRNA levels (Fig. 3H). Because pull-down assays
showed that linc1992 was associated with hnRNPL in linc1992-
overexpressing cells (Fig. S5F), we reasoned that linc1992 and
Fig. 3. Linc1992 functions by interacting with hnRNPL. (A) Experimental
design for pull-down assays and identification of linc1992-associated cellular
proteins. Linc1992 and lacZ RNA were biotinylated by in vitro transcrip-
tion, refolded, and incubated with THP1 total cell lysates. (B) Silver staining
of biotinylated linc1992-associated proteins. Two linc1992-specific bands
(arrows) were excised and analyzed by mass spectrometry, which identified
hnRNPL, DDX5, NONO, and vimentin. (C) Western blotting of proteins from
lacZ and linc1992 pull-down assays. (D) Western blotting of hnRNPL in
samples pulled down by full-length (FL) or truncated linc1992 (Δ1: 1–699, Δ2:
700–1405, and Δ3: 1406–2012). (E) Linc1992 association with hnRNPL. Nu-
clear lysates of THP1 macrophages were immunoprecipitated with control
mouse IgG or anti-hnRNPL antibody, and the complexes were analyzed for the
presence of linc1992 or GAPDH by RT-qPCR. Signals were normalized to actin
mRNA. Results are mean ± SD of two independent experiments with duplicate
wells. **P < 0.01. Specific immunoprecipitation of hnRNPL was confirmed by
Western blotting (Inset). (F) TNFα mRNA levels in THP1 macrophages ex-
pressing NonT shRNA or five shRNAs targeting hnRNPL. TNFα mRNA was an-
alyzed by RT-qPCR. Results are mean ± SD of two independent experiments
with duplicate wells. **P < 0.01. (G) Basal TNFα mRNA levels in hnRNPL-
depleted THP1 macrophages. Experiment was performed as in F except cells
were not treated with Pam. Results are mean ± SD of two independent
experiments with duplicate wells. *P < 0.05. (H) TNFα expression in linc1992-
depleted or linc1992-overexpressing THP1 macrophages. Samples were ana-
lyzed by RT-qPCR 3 d after infection. Results are mean ± SD of two inde-
pendent experiments with duplicate wells. *P < 0.05. (I) ChIP analysis of
hnRNPL association with the TNFα promoter region. ChIP with anti-hnRNPL
or control IgG was performed as described inMaterials and Methods. Results
are expressed as the fold enrichment of TNFα promoter sequence in hnRNPL
compared with IgG ChIP. Results are mean ± SD of three independent
experiments. **P < 0.01. Input samples were analyzed by Western blotting
(Inset) with anti-hnRNPL or anti-actin antibodies. (J) ChIRP analysis of
linc1992 binding to the TNFα promoter. ChIRP was performed as described in
ref. 23. Results are expressed as fold enrichment of TNFα or GAPDH pro-
moter sequence in linc1992 compared with lacZ RNA ChIRP.








hnRNPL might regulate TNFα expression by forming a complex
at the TNFα promoter. Indeed, chromatin immunoprecipitation
(ChIP) assays revealed that hnRNPL bound to the TNFα pro-
moter (Fig. 3I). Furthermore, knockdown of hnRNPL or linc1992
independently reduced binding of hnRNPL to the TNFα pro-
moter (Fig. 3I), suggesting that linc1992–hnRNPL complex bind-
ing at the promoter is required to maintain basal transcription of
TNFα. We also confirmed by ChIRP (chromatin isolation by RNA
purification) assays (23) that linc1992 bound directly to the TNFα
promoter (Fig. 3J). Overexpression of linc1992 didn’t enhance
TNFα expression in hnRNPL knocked down cells (Fig. S5 G and
H), further confirming the collaboration of linc1992 and hnRNPL
to regulate TNFα expression. Notably, knockdown of linc1992 did
not affect hnRNPL expression (Fig. 3I), and Pam treatment didn’t
decrease the expression of hnRNPL (Fig. S5I).
Based on these findings, we propose a model in which hnRNPL
and linc1992 form an RNP complex that regulates basal and
stimulated transcription of TNFα by binding to the TNFα pro-
moter. In activated cells, high levels of TNFα secretion initiate
a negative feedback loop in which linc1992 and, in turn, TNFα
expression is down-regulated (Fig. 4A).
Linc1992 Is Required to Maintain the Expression of Many Innate
Immunity-Associated Genes. To identify additional linc1992-regu-
lated target genes, we performed a transcriptome analysis by RNA-
seq. Next, we analyzed samples of THP1 macrophages expressing
shNonT or shLinc1992 and treated with or without Pam. We chose
shLinc1992 II shRNA for these experiments as it most effectively
reduced linc1992 levels (Fig. 2A). To ensure that changes in
expression of a broad array of innate immunity-associated
genes would be detected, we extended the Pam treatment time to
24 h. Samples from three independent cell incubations were an-
alyzed for each condition by HiSeq2000, and between 10 and 27
million reads per sample were generated with a mapping rate of
more than 80%. Read counts were then further processed to
RPKM (reads per kilobase per million) and analyzed by ANOVA,
with a filter setting of at least a twofold expression change and a
false discovery rate (FDR) = 0.05 (Fig. S6A).
We first compared the results of the control shRNA samples
with or without Pam treatment, reasoning that a significant en-
richment of innate immune genes should be seen in this dataset.
Gene ontology analysis of 618 differentially expressed genes
showed a significant representation of genes usually activated
during an innate immune response (Fig. S6 B and C). These data
validated our overall experimental design and data processing.
We next compared cells expressing shLinc1992 and control
shRNA in the absence of Pam stimulation. Surprisingly, among
the 454 genes significantly modulated by shLinc1992, 444 were
dramatically down-regulated and only 10 were up-regulated (Fig.
S6D), strongly suggesting that linc1992 may be required to
maintain basal transcription of a broad array of genes. Cells
expressing shLinc1992 and shNonT showed no significant dif-
ferences in the expression of cytokine or cytokine receptor genes,
with the exception of a decrease in Bmpr2 expression in
shLinc1992 cells (Fig. S6E), confirming that innate signaling was
not activated in the absence of Pam. Analysis of the dataset from
Pam-stimulated cells indicated that 317 genes were differentially
expressed in control and shLinc1992-expressing cells, of which
101 were up-regulated and 216 were down-regulated by linc1992
knockdown (Fig. 4B). We found 131 overlapping genes in the
shLinc1992 – Pam and shLinc1992 + Pam groups, which was
significant compared with random groups of genes (P = 0.0004,
Fisher’s exact test). Knockdown of linc1992 decreased Pam-
induced expression of cytokines and chemokines in addition to
TNFα (Fig. S6G), including IL-8, CXCL10, CCL1, and CSF1.
Additional genes known to regulate cytokine induction and in-
nate immunity were enriched in Pam-stimulated cells (Fig. S6F
and Table S1), and most of these (24/32, 75%) were decreased
upon knockdown of linc1992. A selection of 22 genes was further
validated by RT-qPCR (Fig. 4C). Interestingly, several of these
genes are involved in the transcriptional and posttranscriptional
regulation of TNFα expression, including the transcription factor
POU2F1 (23), and rhomboid family member 2 (RHBDF2), a
protein that binds to TNFα-converting enzymes to facilitate their
exit from the ER membrane (24). This finding suggests that
linc1992 may modulate aspects of TNFα expression other than
transcription. The expression of many other documented NFκB
target genes was similarly decreased upon knockdown of
linc1992 (Fig. S6H). Collectively, these data demonstrate that
reduced expression of linc1992 dysregulates the induction of
cytokines during innate immune cell activation and strongly
suggest that linc1992 may play a broad role in maintaining
transcription of an array of genes. Based on the similar experi-
ment, hnRNPL was knocked down, and 22 genes, which were
selected as the potential targets of linc1992, were further vali-
dated by RT-qPCR. Four genes, protein kinase C alpha (PRKCA),
RAGEF1B, MMP9, and RHBDF2, showed the same trend with
the treatment of Pam as that shown in linc1992 knocked down cells
(Fig. S7A). We further tested the binding of linc1992 to the pro-
moters of PRKCA and RHBDF2 and found that linc1992 was
indeed enriched at these loci, but not in MALT1 (Fig. S7B). Fur-
thermore, linc7705 and 2807 were not associated with hnRNPL
(Fig. S7C). These results further indicate that linc1992 and
hnRNPL interact with each other specifically and may work
together to regulate downstream genes. Given its importance
in TNFα induction, hnRNPL binding, and the innate immune
response, we named linc1992 THRIL (TNFα and hnRNPL Re-
lated Immunoregulatory LincRNA).
THRIL Expression Is Associated with Kawasaki Disease. To determine
whether THRIL expression is modulated in human inflammatory
diseases, we examined RNA samples from patients with Kawa-
saki disease, an acute self-limiting vasculitis of children that can
lead to cardiovascular damage (24). The disease course is char-
acterized by an acute phase, during which serum TNFα levels are
elevated, followed by a convalescent phase. We compared the
Fig. 4. Linc1992 knockdown dysregulates expression of innate immunity-
associated genes. (A) Model for THRIL-mediated regulation of TNFα gene
expression. (B) Identification of differentially expressed genes in Pam-stimu-
lated THP1 macrophages expressing control or linc1992-targeting shRNA.
Datasets were compared by ANOVA and filtered using a twofold change in
expression and FDR of 0.05. (C) Validation of changes in gene expression by
RT-qPCR. Of the 32 genes listed in Table S1, 22 with a single transcript were
selected for validation. Results are mean ± SD of two independent experi-
ments with duplicate wells. (D) THRIL expression in the blood of Kawasaki
disease patients. Whole blood samples were obtained from 17 patients during
the acute phase of disease (before treatment) and 1–2 mo later during the
convalescent phase. THRIL expression was measured by RT-PCR. Data were
calculated using the 2^ (delta Ct) method and analyzed with Student t test.
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expression of lincRNAs in paired samples of whole blood taken
from 17 patients during the acute phase of disease (before
treatment with i.v. Ig) and during the posttreatment convalescent
phase when inflammation is resolving. The convalescent phase
samples were collected within 1–2 mo of the acute phase, when
the erythrocyte sedimentation rate and the platelet count had
returned to normal. We observed that THRIL expression was
significantly lower in the acute phase than in the convalescent
phase (Fig. 4D). Expression levels did not correlate with the day
of illness on which the sample was drawn (Fig. S6I), acute levels of
C-reactive protein, white blood cell counts, or erythrocyte sedi-
mentation rate, suggesting complex regulation of the innate im-
mune response in these patients. THRIL expression was clearly
lower during the acute phase of disease when TNFα levels were
elevated. This effect mirrors the negative feedback loop of THRIL
regulation demonstrated in our in vitro experiments and suggests
that THRIL could be a novel biomarker for immune activation.
Discussion
The complete sequencing of the human genome revealed many
surprises, particularly that a large portion of the genome was
composed of noncoding regions. Many of these regions are actively
transcribed into mRNAs and other RNA species. Among them,
lincRNAs have been shown to be involved in regulating many
important processes (6, 7, 9, 11, 25, 26) and exhibit cross-species
conservation of their genomic loci but not of their sequences (13).
LincRNA research is a rapidly expanding field and novel functions
for lincRNAs will undoubtedly continue to be discovered.
In this study, we systematically analyzed the change in ex-
pression of lincRNAs upon activation of innate immune signal-
ing in THP1 macrophages. Through a combination of genomic,
biochemical, and cell biological approaches, we identified an
unannotated lincRNA, termed THRIL, as a key player in regu-
lating TNFα expression in these cells (Fig. 4A). Based on our
result, THRIL was shown to function through forming an RNA–
protein complex with hnRNPL, a protein involved in the stress
response (18) but not previously documented to have a role in
innate immunity. Our data does not rule out the possibility that
the interaction of THRIL with hnRNPL may be mediated by
other unidentified cellular factors within the protein complex.
Meanwhile, transcriptome analysis of knockdown cells revealed
that loss of THRIL dysregulated the expression of additional
immune-associated genes, many of which play well-documented
roles in innate immunity. Therefore, THRIL may have a broad
impact on many aspects of immunity that should be addressed
further. In addition, our disease-association study indicated a
positive association between decreased expression of THRIL and
the acute phase of Kawasaki disease. The involvement of THRIL
in TNFα regulation strongly suggests that it may also contribute
to other common inflammatory diseases such as rheumatoid
arthritis and inflammatory bowel disease, and thus further in-
vestigation of THRIL expression in human disease is warranted.
This study reports a lincRNA functioning in the regulation of
innate immune signaling, and our data provide the proof of
concept that lincRNAs could be key players in regulating various
host–pathogen interactions. Recently, two groups reported
lncRNAs regulating innate immunity (27, 28). An enhancer-
like lncRNA termed NeST [nettoie Salmonella pas Theiler’s
(cleanup Salmonella not Theiler’s)] was reported to regulate
epigenetic marking of IFN-gamma-encoding chromatin, expression
of IFN-gamma, and susceptibility to a viral and a bacterial pathogen
(27). Intriguingly, lincRNA-Cox2, a key regulator of inflammatory
response, modulates both the activation and repression of immune
response genes (28). Many lincRNAs and their mechanisms in
regulating immunity and hos-pathogen biology will emerge in future.
Materials and Methods
shRNA Design and Vector Construction. shRNA sequences were designed using
the open-access tool from the Broad Institute. Probes containing both sense
and antisense strands of shRNAs were cloned into the pLKO.1-puro lentiviral
vector (Dataset S1).
ELISAs for Secreted TNFα and IL-6. Lentivirus-infected THP1 macrophages were
treated with 100 ng/mL Pam3CSK4 for 24 h, and the culture supernatants
were collected. TNFα and IL-6 levels were measured by ELISA (eBioscience)
according to the manufacturer’s instructions.
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